glp 1 drugs heart failure Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology Heart attack: Drugs like Ozempic

the STEP 5 trial represents the most extensive study on the use of semaglutide for weight management to date

Development of activity-based anorexia requires PKC- neurons in two central extended amygdala nuclei

This finding was consistent for cardiovascular mortality (HR 0.90, 95% CI from 0.50 to 1.61) and all-cause mortality (HR 0.80, 95% CI from 0.51 to 1.25)

Nearly a decade on - trends, risk factors and policy implications in global obesity

This method has inherent limitations and data should be treated with caution

FDA labeling notes that delayed gastric emptying may affect absorption of oral medications and that these agents are not recommended for patients with severe gastroparesis